Recorded Chinese product: 三磷酸腺苷二钠片三磷酸腺苷二钠片

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

三磷酸腺苷二钠是一种在国家药监局注册认定的药品。该药品含有三磷酸腺苷二钠-15eca7d7等成分。

该药品关联的活性成分包括:三磷酸腺苷二钠Sanlin Suanxian Ganer Na。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:广东三才石岐制药股份有限公司Chinese legal name: 广东三才石岐制药股份有限公司。

您可以探索含有相同成分的其他药品:三磷酸腺苷二钠-15eca7d7成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 三磷酸腺苷二钠片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 三磷酸腺苷二钠Sanlin Suanxian Ganer Na.

Manufacturers recorded for this product: 广东三才石岐制药股份有限公司Chinese legal name: 广东三才石岐制药股份有限公司.

Explore other medicines containing the same ingredient: 三磷酸腺苷二钠 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 三磷酸腺苷二钠片Recorded Chinese product: 三磷酸腺苷二钠片
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 20mg。20 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 广东三才石岐制药股份有限公司Chinese legal name: 广东三才石岐制药股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H44024643

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H44024643

Manufacturer

Chinese legal name: 广东三才石岐制药股份有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H44024643

生产企业

广东三才石岐制药股份有限公司(国产)

适应症

1、适用于维生素B6缺乏的预防和治疗,防治异烟肼中毒;也可用于妊娠、放射病及抗癌药所致的呕吐,脂溢性皮炎等。
2、全胃肠道外营养及因摄入不足所致营养不良、进行性体重下降时维生素 B6的补充。
3、下列情况对维生素B6需要量增加:妊娠及哺乳期、甲状腺功能亢进、烧伤、长期慢性感染、发热、先天性代谢障碍病(胱硫醚尿症、高草酸盐症、高胱氨酸尿症、黄嘌呤酸尿症)、充血性心力衰竭、长期血液透析、吸收不良综合症伴肝胆系统疾病(如酒精中毒伴肝硬化)、肠道疾病(乳糜泻、热带口炎性肠炎、局限性肠炎、持续腹泻)、胃切除术后。
4、新生儿遗传性维生素B6依赖综合征。

用法用量

口服,一次1-2片,一日3次。用量可根据年龄及症状酌情增减。

不良反应

尚未见有关不良反应报道。

禁忌

对本品过敏者禁用。

注意事项

1、脑出血初期患者禁用。
2、当药品性状发生改变时禁止使用。

贮藏

遮光,密闭保存。

规格

20mg。

证据Evidence

  • 批准文号: 国药准字H44024643
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.